DXCM
$58.23
Revenue | $1209.3Mn |
Net Profits | $283.8Mn |
Net Profit Margins | 23.47% |
Dexcom, Inc.’s revenue jumped 21.64% since last year same period to $1209.3Mn in the Q3 2025. On a quarterly growth basis, Dexcom, Inc. has generated 4.51% jump in its revenue since last 3-months.
Dexcom, Inc.’s net profit jumped 110.85% since last year same period to $283.8Mn in the Q3 2025. On a quarterly growth basis, Dexcom, Inc. has generated 57.84% jump in its net profits since last 3-months.
Dexcom, Inc.’s net profit margin jumped 73.34% since last year same period to 23.47% in the Q3 2025. On a quarterly growth basis, Dexcom, Inc. has generated 51.03% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.57 |
EPS Estimate Current Year | 0.57 |
Dexcom, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.57 - a 29.55% jump from last quarter’s estimates.
Dexcom, Inc.’s earning per share (EPS) estimates for the current year stand at 0.57.
Earning Per Share (EPS) | 0 |
Dexcom, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Dexcom, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-01 | 0.33 | 0.32 | -3.03% |
2025-10-30 | 0.57 | 0 | -100% |
2025-07-30 | 0.44 | 0.48 | 9.09% |